Fort Myers, FL, November 13, 2010 --(PR.com
)-- Florida-based 21st Century Oncology has been selected to develop New York’s first proton-beam cancer treatment center in Manhattan with a group of the nation’s leading cancer institutions.
The consortium, which includes New York City hospitals Memorial Sloan-Kettering Cancer Center, Beth Israel Medical Center, NYU Langone Medical Center, Montefiore Medical Center and Mount Sinai Medical Center, will be known as the New York Proton Center. There are only eight proton-beam treatment centers currently operating in the U.S., with another six under construction or being planned, according to the National Association for Proton Therapy.
“We’re honored to be included in this elite group of top cancer treatment centers, and excited to move forward the treatment of cancer with proton-beam therapy,” says Norton Travis, Executive Vice President of 21st Century Oncology who helped direct the approval process for the consortium. “Our selection to lead this effort is an endorsement of 21st Century Oncology’s reputation for clinical excellence and being first to market with technologically-advanced treatments.”
About 21st Century Oncology
Founded by a small group of physicians in Fort Myers, Fla. in 1985, 21st Century Oncology has grown into a leading developer and operator of radiation therapy centers in the U.S. Still headquartered in Fort Myers, the company also operates gynecologic, urologic, and medical oncology practices and surgery centers that complement its cancer treatment focus. 21st Century Oncology has been committed to providing premier, quality, cost-effective radiation therapy services that are responsive to the needs of its patients through continuous improvement and innovation. The company has nearly 200 locations in 15 states.
For further information, contact:
Mary Briggs, APR, CPRC
Public relations counsel
239-278-3900 or cell 239-851-0136